Smithfield Drops Claims In Neurontin Class Action

Law360, New York (March 2, 2009, 12:00 AM EST) -- Several end-payor plaintiffs, including Smithfield Foods Inc., have voluntarily dismissed all claims against Pfizer Inc. in a consolidated class action that accused the pharmaceutical company of engaging in an anti-competitive scheme to delay generic competition for the epilepsy drug Neurontin.

Smithfield and four individual consumer plaintiffs lodged stipulations of voluntary dismissal on Thursday and Friday in the U.S. District Court for the District of New Jersey, where litigation against Pfizer and its Warner-Lambert Co. subsidiary has been pending since 2002.

According to the stipulations, the end-payor...
To view the full article, register now.